Chipscreen
formerly Chipscreen BiosciencesIPOChipscreen was founded in 2001, is headquartered in Shenzhen, China, and lists 501–1000 employees.
- Headquarters
- Shenzhen
- Employees
- 501–1000
- Founded
- 2001
- Business Model
- B2B
- Website
- chipscreen.com
- Type
- Public
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Shenzhen Chipscreen Biosciences Co., Ltd. is a pioneering Chinese biopharmaceutical company founded in 2001 by a team of senior PhD returnee scientists, and the first biopharmaceutical company to list on China's STAR Market (stock code: 688321.SH). Chipscreen operates as an integrated drug discovery and development enterprise, leveraging a proprietary chemical genomics-based platform and AI-assisted design to identify novel small molecule therapeutics across oncology, metabolic diseases, autoimmune disorders, central nervous system disorders, and antiviral indications. Its approved products include Chidamide, a selective histone deacetylase inhibitor for peripheral T-cell lymphoma and breast cancer, and Chiglitazar for type 2 diabetes. The company employs approximately 1,000 people across its Shenzhen headquarters, Chengdu R&D and GMP production base, Beijing clinical research center, and Shanghai commercial center.
Summary
Chipscreen is a Biotech company based in Shenzhen, China, founded in 2001. It lists 501–1000 employees.
Exit History
Aug 2019
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/chipscreen"><img src="https://indexed.vc/api/badge/company/chipscreen" alt="Chipscreen on Indexed.vc" width="260" height="76" /></a>